Anaplastic Large-Cell Lymphoma in Women With Breast Implants

Jong, Daphne de; Vasmel, W. L. E.; Boer, Jan Paul de; Verhave, Gideon; Barbé, Ellis; Casparie, Mariël K.; Leeuwen, Flora E. van

doi:10.1001/jama.2008.585

Cited by 323 publications

(214 citation statements)

References 22 publications

(20 reference statements)

Supporting

Mentioning

195

Contrasting

Unclassified

Order By: Relevance

“…[29][30][31] These lymphomas are CD30 positive and ALK negative. Patients usually present with swelling associated with a seroma and discomfort in a breast containing a silicone-coated implant.…”

Section: Anaplastic Large-cell Lymphomamentioning

confidence: 99%

See 1 more Smart Citation

The aggressive peripheral T‐cell lymphomas: 2015

Armitage

2015

American J Hematol

View full text Add to dashboard Cite

Background: T‐cell lymphomas make up approximately 10%–15% of lymphoid malignancies. The frequency of these lymphomas varies geographically, with the highest incidence in parts of Asia.Diagnosis: The diagnosis of aggressive peripheral T‐cell lymphoma (PTCL) is usually made using the World Health Organization classification. The ability of hematopathologists to reproducibly diagnosis aggressive PTCL is lower than that for aggressive B‐cell lymphomas, with a range of 72%–97% for the aggressive PTCLs.Risk Stratification: Patients with aggressive PTCL are staged using the Ann Arbor Classification. Although somewhat controversial, positron emission tomography scans seem to be useful as they are in aggressive B‐cell lymphomas. The most commonly used prognostic index is the International Prognostic Index. The specific subtype of aggressive PTCL is an important risk factor, with the best survival seen in anaplastic large‐cell lymphoma—particularly young patients with the anaplastic lymphoma kinase positive subtype.Risk‐Adapted Therapy: Anaplastic large‐cell lymphoma is the only subgroup to have a good response to a CHOP‐like regimen. Angioimmunoblastic T‐cell lymphoma has a prolonged disease‐free survival in only ∼20% of patients, but younger patients who have an autotransplant in remission seem to do better. PTCL‐not otherwise specified is not one disease. Anthracycline‐containing regimens have disappointing results, and a new approach is needed. Natural killer/T‐cell lymphoma localized to the nose and nasal sinuses seems to be best treated with radiotherapy‐containing regimens. Enteropathy‐associated PTCL and hepatosplenic PTCL are rare disorders with a generally poor response to therapy, although selected patients with enteropathy‐associated PTCL seem to benefit from intensive therapy. Am. J. Hematol. 90:666–673, 2015. © 2015 Wiley Periodicals, Inc.

show abstract

Section: Anaplastic Large-cell Lymphomamentioning

confidence: 99%

“…Although a variety of subtypes of lymphoma can arise in this situation [56], anaplastic large-cell lymphoma seems particularly frequent. Patients with this presentation of anaplastic large-cell lymphoma should have the implant removed.…”

Section: Risk-adapted Therapy Of Specific Subtypesmentioning

confidence: 99%

The aggressive peripheral T‐cell lymphomas: 2015

Armitage

2015

American J Hematol

View full text Add to dashboard Cite

show abstract

“…The chromosomal translocation t(2;5)(p23;q35), which results in the fusion protein NPM-ALK (2), is found specifically in ALCL. A possible link between breast implants and ALCL has also been reported (13)(14)(15)(16)(17)(18). While these risk factors do not explain the majority of PTCLs that arise, they do suggest that PTCL subtypes may have distinct etiologies.…”

mentioning

confidence: 99%

Medical History, Lifestyle, Family History, and Occupational Risk Factors for Peripheral T-Cell Lymphomas: The InterLymph Non-Hodgkin Lymphoma Subtypes Project

et al. 2014

View full text Add to dashboard Cite

show abstract

“…The most common clinical presentation is unilateral breast swelling because of the periprothesic fluid, which presents 1 year after surgery or as a palpable cutaneous mass or solid mass attached to the implant capsule [4].…”

Section: Discussionmentioning

confidence: 99%